<DOC>
	<DOCNO>NCT00944697</DOCNO>
	<brief_summary>To show superior analgesic efficacy OXN PR addition patient 's current dose pregabalin compare pregabalin alone .</brief_summary>
	<brief_title>A Study Demonstrate Analgesic Efficacy Oxycodone/Naloxone Prolonged Release Tablets Addition Pregabalin Compared Pregabalin Alone Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate Severe Pain Due Diabetic Polyneuropathy</brief_title>
	<detailed_description>Study OXN2502 pilot , exploratory , randomise , placebo-controlled , double-blind , single-dummy , parallel group study assess efficacy safety OXN PR addition patient 's current dose pregabalin compare pregabalin alone opioid-naïve subject treat pregabalin suffer moderate severe pain due diabetic polyneuropathy .</detailed_description>
	<mesh_term>Polyneuropathies</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Oxycodone</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Inclusion criterion : Moderate severe pain due diabetic polyneuropathy Opioidnaive subject Exclusion criterion : Females pregnant lactate Subjects evidence significant structural abnormality gastrointestinal tract Subjects evidence impair liver/kidney function upon entry study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>